No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant

Charlotte B. Acharya; John Schrom; Anthea M. Mitchell; David A. Coil; Carina Marquez; Susana Rojas; Chung Yu Wang; Jamin Liu; Genay Pilarowski; Leslie Solis; Elizabeth Georgian; Maya Petersen; Joseph DeRisi; Richard Michelmore; Diane Havlir.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21264262

Documentos relacionados

  1. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
  2. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
  3. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
  4. Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab.
  5. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  6. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children.
  7. Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19.
  8. Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection.
  9. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.
  10. Measures implemented in the school setting to contain the COVID-19 pandemic